The statements in this press release regarding Stratasys' strategy, and the statements regarding its projected future financial performance, including the financial guidance concerning its expected results for 2022 and beyond, are forward-looking statements reflecting management's current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys' business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the degree of our success at introducing new or improved products and solutions that gain market share; the degree of growth of the 3D printing market generally; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower margin products or services; the impact of competition and new technologies; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; the extent of our success at successfully consummating and integrating into our existing business acquisitions or investments in new businesses, technologies, products or services; the strength and duration of, and degree of recovery from, the COVID-19 pandemic in the markets in which we operate; potential changes in our management and board of directors; global market, political and economic conditions, and in the countries in which we operate in particular (including risks related to the impact of coronavirus on our supply chain and business); costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual property rights by others or infringement of others' intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D “Key Information - Risk Factors”, Item 4, “Information on the Company”, Item 5, “Operating and Financial Review and Prospects,” and all other parts of our Annual Report on Form 20-F for the year ended December 31, 2021, which we are filing with the U.S. Securities and Exchange Commission, or SEC, on or about the date hereof (the “2021 Annual Report”). Readers are urged to carefully review and consider the various disclosures made throughout our 2021 Annual Report and the Reports of Foreign Private Issuer on Form 6-K that attach Stratasys’ unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition, for the quarterly periods throughout 2022, which will be furnished to the SEC throughout 2022, and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this press release are provided or made (as applicable) as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Use of Non-GAAP Financial Measures
The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, legal provisions and (ii) excluding non-cash items such as stock-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.
Stratasys Ltd. | |||||||||
Consolidated Balance Sheets | |||||||||
(in thousands, except share data) | |||||||||
December 31, |
December 31, |
||||||||
|
2021 |
|
|
2020 |
|
||||
ASSETS | |||||||||
Current assets | |||||||||
Cash and cash equivalents | $ |
243,179 |
|
$ |
272,092 |
|
|||
Short-term deposits |
|
259,000 |
|
|
27,000 |
|
|||
Accounts receivable, net of allowance for credit losses of $0.5 and $0.9 million as of December 31, 2021 and December 31, 2020 |
|
129,382 |
|
|
106,068 |
|
|||
Inventories |
|
129,147 |
|
|
131,672 |
|
|||
Prepaid expenses |
|
6,871 |
|
|
6,717 |
|
|||
Other current assets |
|
33,123 |
|
|
16,943 |
|
|||
Total current assets |
|
800,702 |
|
|
560,492 |
|
|||
Non-current assets | |||||||||
Property, plant and equipment, net |
|
203,295 |
|
|
201,232 |
|
|||
Goodwill |
|
65,144 |
|
|
35,694 |
|
|||
Other intangible assets, net |
|
152,244 |
|
|
131,569 |
|
|||
Operating lease right-of-use assets |
|
14,651 |
|
|
21,298 |
|
|||
Long-term investments |
|
28,667 |
|
|
24,268 |
|
|||
Other non-current assets |
|
12,519 |
|
|
15,449 |
|
|||
Total non-current assets |
|
476,520 |
|
|
429,510 |
|
|||
Total assets | $ |
1,277,222 |
|
$ |
990,002 |
|
|||
LIABILITIES AND EQUITY | |||||||||
Current liabilities | |||||||||
Accounts payable | $ |
51,976 |
|
$ |
16,987 |
|
|||
Accrued expenses and other current liabilities |
|
55,358 |
|
|
31,061 |
|
|||
Accrued compensation and related benefits |
|
44,684 |
|
|
25,659 |
|
|||
Deferred revenues - short term |
|
51,174 |
|
|
49,165 |
|
|||
Operating lease liabilities - short term |
|
7,276 |
|
|
9,282 |
|
|||
Total current liabilities |
|
210,468 |
|
|
132,154 |
|
|||
Non-current liabilities | |||||||||
Deferred revenues - long term |
|
21,133 |
|
|
14,227 |
|
|||
Deferred income taxes |
|
7,341 |
|
|
42 |
|
|||
Operating lease liabilities - long term |
|
7,693 |
|
|
12,567 |
|
|||
Contingent consideration |
|
53,478 |
|
|
37,400 |
|
|||
Other non-current liabilities |
|
21,095 |
|
|
34,017 |
|
|||
Total non-current liabilities |
|
110,740 |
|
|
98,253 |
|
|||
Total liabilities |
|
321,208 |
|
|
230,407 |
|
|||
Redeemable non-controlling interests |
|
- |
|
|
227 |
|
|||
Equity | |||||||||
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands | |||||||||
shares; 65,667 thousands shares and 56,617 thousands shares issued | |||||||||
and outstanding at December 31, 2021 and December 31, 2020, respectively |
|
182 |
|
|
155 |
|
|||
Additional paid-in capital |
|
3,012,481 |
|
|
2,753,955 |
|
|||
Accumulated other comprehensive loss |
|
(8,771 |
) |
|
(8,846 |
) |
|||
Accumulated deficit |
|
(2,047,878 |
) |
|
(1,985,896 |
) |
|||
Total equity |
|
956,014 |
|
|
759,368 |
|
|||
Total liabilities and equity | $ |
1,277,222 |
|
$ |
990,002 |
|
Stratasys Ltd. | |||||||||||||||||
Consolidated Statements of Operations | |||||||||||||||||
(in thousands, except per share data) | |||||||||||||||||
Three Months Ended December 31, |
Twelve Months Ended December 31, |
||||||||||||||||
|
2021 |
|
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|||||
(Unaudited) |
|
(Unaudited) |
|||||||||||||||
Net sales | |||||||||||||||||
Products | $ |
118,040 |
|
$ |
99,185 |
|
$ |
417,557 |
|
$ |
339,782 |
|
|||||
Services |
|
48,976 |
|
|
43,210 |
|
|
189,662 |
|
|
181,035 |
|
|||||
|
167,016 |
|
|
142,395 |
|
|
607,219 |
|
|
520,817 |
|
||||||
Cost of sales | |||||||||||||||||
Products |
|
59,470 |
|
|
44,679 |
|
|
210,941 |
|
|
171,235 |
|
|||||
Services |
|
34,503 |
|
|
31,697 |
|
|
136,200 |
|
|
130,188 |
|
|||||
|
93,973 |
|
|
76,376 |
|
|
347,141 |
|
|
301,423 |
|
||||||
Gross profit |
|
73,043 |
|
|
66,019 |
|
|
260,078 |
|
|
219,394 |
|
|||||
Operating expenses | |||||||||||||||||
Research and development, net |
|
22,620 |
|
|
18,953 |
|
|
88,303 |
|
|
84,012 |
|
|||||
Selling, general and administrative |
|
66,584 |
|
|
49,595 |
|
|
250,937 |
|
|
205,224 |
|
|||||
Goodwill impairment |
|
- |
|
|
- |
|
|
- |
|
|
386,154 |
|
|||||
|
89,204 |
|
|
68,548 |
|
|
339,240 |
|
|
675,390 |
|
||||||
Operating loss |
|
(16,161 |
) |
|
(2,529 |
) |
|
(79,162 |
) |
|
(455,996 |
) |
|||||
Gain from step acquisition |
|
14,400 |
|
|
- |
|
|
14,400 |
|
|
- |
|
|||||
Financial income (expense), net |
|
(692 |
) |
|
273 |
|
|
(2,075 |
) |
|
(575 |
) |
|||||
Loss before income taxes |
|
(2,453 |
) |
|
(2,256 |
) |
|
(66,837 |
) |
|
(456,571 |
) |
|||||
Income tax benefit (expenses) |
|
(2,103 |
) |
|
14,144 |
|
|
3,906 |
|
|
16,394 |
|
|||||
Share in profit (loss) of associated companies |
|
(280 |
) |
|
(1,200 |
) |
|
949 |
|
|
(3,939 |
) |
|||||
Net income (loss) |
|
(4,836 |
) |
|
10,688 |
|
|
(61,982 |
) |
|
(444,116 |
) |
|||||
Net loss attributable to non-controlling interests |
|
- |
|
|
(341 |
) |
|
- |
|
|
(395 |
) |
|||||
Net income (loss) attributable to Stratasys Ltd. | $ |
(4,836 |
) |
$ |
11,029 |
|
$ |
(61,982 |
) |
$ |
(443,721 |
) |
|||||
Net income (loss) per ordinary share attributable to Stratasys Ltd. | |||||||||||||||||
Basic | $ |
(0.07 |
) |
$ |
0.20 |
|
$ |
(0.98 |
) |
$ |
(8.08 |
) |
|||||
Diluted | $ |
(0.07 |
) |
$ |
0.20 |
|
$ |
(0.98 |
) |
$ |
(8.08 |
) |
|||||
Weighted average ordinary shares outstanding | |||||||||||||||||
Basic |
|
65,196 |
|
|
55,118 |
|
|
63,471 |
|
|
54,918 |
|
|||||
Diluted |
|
65,196 |
|
|
55,318 |
|
|
63,471 |
|
|
54,918 |
|
Three Months Ended December 31, |
|||||||||||||||||||||||
|
2021 |
|
|
Non-GAAP |
|
|
2021 |
|
|
2020 |
|
|
Non-GAAP |
|
|
2020 |
|||||||
GAAP |
|
Adjustments |
|
Non-GAAP |
|
GAAP |
|
Adjustments |
|
Non-GAAP |
|||||||||||||
U.S. dollars and shares in thousands (except per share amounts) |
|||||||||||||||||||||||
Gross profit (1) | $ |
73,043 |
|
$ |
8,255 |
|
$ |
81,298 |
$ |
66,019 |
|
$ |
4,520 |
|
$ |
70,539 |
|||||||
Operating income (loss) (1,2) |
|
(16,161 |
) |
|
17,822 |
|
|
1,661 |
|
(2,529 |
) |
|
10,861 |
|
|
8,332 |
|||||||
Net income (loss) attributable to
Stratasys Ltd. (1,2,3) |
|
(4,836 |
) |
|
5,355 |
|
|
519 |
|
11,029 |
|
|
(4,001 |
) |
|
7,028 |
|||||||
Net income (loss) per diluted share attributable
to Stratasys Ltd. (4) |
$ |
(0.07 |
) |
$ |
0.08 |
|
$ |
0.01 |
$ |
0.20 |
|
$ |
(0.07 |
) |
$ |
0.13 |
|||||||
(1) |
Acquired intangible assets amortization expense |
|
6,024 |
|
|
3,411 |
|
||||||||||||||||
Non-cash stock-based compensation expense |
|
866 |
|
|
347 |
|
|||||||||||||||||
Restructuring and other related costs |
|
1,185 |
|
|
762 |
|
|||||||||||||||||
Impairment charges |
|
180 |
|
|
- |
|
|||||||||||||||||
|
8,255 |
|
|
4,520 |
|
||||||||||||||||||
(2) |
Acquired intangible assets amortization expense |
|
2,280 |
|
|
2,290 |
|
||||||||||||||||
Non-cash stock-based compensation expense |
|
6,971 |
|
|
3,962 |
|
|||||||||||||||||
Restructuring and other related costs |
|
373 |
|
|
449 |
|
|||||||||||||||||
Revaluation of investments |
|
(1,859 |
) |
|
- |
|
|||||||||||||||||
Contingent consideration |
|
(20 |
) |
|
- |
|
|||||||||||||||||
Legal and other expenses (income) |
|
1,823 |
|
|
(360 |
) |
|||||||||||||||||
|
9,568 |
|
|
6,341 |
|
||||||||||||||||||
|
17,822 |
|
|
10,861 |
|
||||||||||||||||||
(3) |
Corresponding tax effect |
|
1,906 |
|
|
(15,009 |
) |
||||||||||||||||
Equity method related amortization, divestments and impairments |
|
27 |
|
|
483 |
|
|||||||||||||||||
Adjustments attributable to non-controlling interest |
|
- |
|
|
(336 |
) |
|||||||||||||||||
Gain from obtaining control |
|
(14,400 |
) |
|
- |
|
|||||||||||||||||
$ |
5,355 |
|
$ |
(4,001 |
) |
||||||||||||||||||
(4) |
Weighted average number of ordinary
shares outstanding- Diluted |
|
65,196 |
|
|
66,820 |
|
55,318 |
|
|
55,318 |
Twelve Months Ended December 31, |
|||||||||||||||||||||||||
|
2021 |
|
|
Non-GAAP |
|
|
2021 |
|
|
|
2020 |
|
|
Non-GAAP |
|
|
2020 |
|
|||||||
GAAP |
|
Adjustments |
|
Non-GAAP |
|
GAAP |
|
Adjustments |
|
Non-GAAP |
|||||||||||||||
U.S. dollars and shares in thousands (except per share amounts) |
|||||||||||||||||||||||||
Gross profit (1) | $ |
260,078 |
|
$ |
30,447 |
|
$ |
290,525 |
|
$ |
219,394 |
|
$ |
28,582 |
|
$ |
247,976 |
|
|||||||
Operating income (loss) (1,2) |
|
(79,162 |
) |
|
77,479 |
|
|
(1,683 |
) |
|
(455,996 |
) |
|
446,848 |
|
|
(9,148 |
) |
|||||||
Net income (loss) attributable to
Stratasys Ltd. (1,2,3) |
|
(61,982 |
) |
|
57,639 |
|
|
(4,343 |
) |
|
(443,721 |
) |
|
429,820 |
|
|
(13,901 |
) |
|||||||
Net income (loss) per diluted share attributable
to Stratasys Ltd. (4) |
$ |
(0.98 |
) |
$ |
0.91 |
|
$ |
(0.07 |
) |
$ |
(8.08 |
) |
$ |
7.83 |
|
$ |
(0.25 |
) |
|||||||
(1) |
Acquired intangible assets amortization expense |
|
22,392 |
|
|
15,607 |
|
||||||||||||||||||
Non-cash stock-based compensation expense |
|
3,092 |
|
|
1,771 |
|
|||||||||||||||||||
Restructuring and other related costs |
|
1,642 |
|
|
5,948 |
|
|||||||||||||||||||
Impairment charges |
|
3,321 |
|
|
5,256 |
|
|||||||||||||||||||
|
30,447 |
|
|
28,582 |
|
||||||||||||||||||||
(2) |
Acquired intangible assets amortization expense |
|
8,878 |
|
|
8,720 |
|
||||||||||||||||||
Non-cash stock-based compensation expense |
|
27,885 |
|
|
18,433 |
|
|||||||||||||||||||
Goodwill impairment |
|
- |
|
|
386,154 |
|
|||||||||||||||||||
Impairment of long-lived assets |
|
1,447 |
|
|
- |
|
|||||||||||||||||||
Restructuring and other related costs |
|
2,743 |
|
|
4,312 |
|
|||||||||||||||||||
Revaluation of investments |
|
(1,303 |
) |
|
- |
|
|||||||||||||||||||
Contingent consideration |
|
570 |
|
|
- |
|
|||||||||||||||||||
Legal and other expenses |
|
6,812 |
|
|
647 |
|
|||||||||||||||||||
|
47,032 |
|
|
418,266 |
|
||||||||||||||||||||
|
77,479 |
|
|
446,848 |
|
||||||||||||||||||||
(3) |
Corresponding tax effect |
|
(864 |
) |
|
(17,405 |
) |
||||||||||||||||||
Equity method related amortization, divestments and impairments |
|
(4,576 |
) |
|
713 |
|
|||||||||||||||||||
Adjustments attributable to non-controlling interest |
|
- |
|
|
(336 |
) |
|||||||||||||||||||
Gain from obtaining control |
|
(14,400 |
) |
|
- |
|
|||||||||||||||||||
$ |
57,639 |
|
$ |
429,820 |
|
||||||||||||||||||||
(4) |
Weighted average number of ordinary
shares outstanding- Diluted |
|
63,471 |
|
|
63,471 |
|
|
54,918 |
|
|
54,918 |
|
Stratasys Ltd. | |||
Reconciliation of GAAP to Non-GAAP Forward Looking Guidance | |||
Fiscal Year 2022 | |||
(in millions, except per share data) | |||
GAAP net loss | ($74) to ($67) |
||
|
|||
Adjustments |
|
||
Stock-based compensation expense | $31 to $33 |
||
Intangible assets amortization expense | $37 to $38 |
||
Reorganization Related Expense | $14 to $15 |
||
Tax expense (benefit) related to Non-GAAP adjustments | ($2) to ($1) |
||
|
|||
Non-GAAP net income | $10 to $13 |
||
|
|||
GAAP diluted loss per share | ($1.11) to ($1.00) |
||
|
|||
Non-GAAP diluted earnings per share | $0.14 to $0.19 |